Cite Filings / BBTX / 0002085929-26-000014

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Bambusa Therapeutics, Inc. Filed 2026-11-05 Acc 0002085929-26-000014

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-11-06 SCHEDULE 13D Beneficial Ownership Report
2026-11-05 SCHEDULE 13G Statement of Beneficial Ownership
2026-11-03 8-K Bylaws or fiscal year change · Regulation FD disclosure
2026-11-03 4 Director bought 2,953,820 shares at an average $15.79 ($46,639,957)
2026-11-02 4 10% owner bought 375,000 shares at $16.00 ($6,000,000)
2026-11-02 4 See remarks acquired 163,596 shares (conversion)
2026-11-02 4 Options or other derivatives

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…